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Background: Ascites is a major and common complication of liver cirrhosis. Large or refractory ascites frequently
necessitates paracentesis. The aim of our study was to investigate the effects of paracentesis on hemodynamic and
respiratory parameters in critically ill patients.
Methods: Observational study comparing hemodynamic and respiratory parameters before and after paracentesis
in 50 critically ill patients with advanced hemodynamic monitoring. 28/50 (56%) required mechanical ventilation.
Descriptive statistics are presented as mean ± standard deviation for normally distributed data and median, range,
and interquartile range (IQR) for non-normally distributed data. Comparisons of hemodynamic and respiratory
parameters before and after paracentesis were performed by Wilcoxon signed-rank tests. Bivariate relations were
assessed by Spearman’s correlation coefficient and univariate regression analyses.
Results: Median amount of ascites removed was 5.99 L (IQR, 3.33-7.68 L). There were no statistically significant
changes in hemodynamic parameters except a decrease in mean arterial pressure (−7 mm Hg; p = 0.041) and in
systemic vascular resistance index (−116 dyne·sec/cm5/m2; p = 0.016) when measured 2 hours after paracentesis.
In all patients, oxygenation ratio (PaO2/FiO2; median, 220 mmHg; IQR, 161–329 mmHg) increased significantly when
measured immediately (+58 mmHg; p = 0.001), 2 hours (+9 mmHg; p = 0.004), and 6 hours (+6 mmHg); p = 0.050)
after paracentesis. In mechanically ventilated patients, lung injury score (cumulative points without x-ray; median,
6; IQR, 4–7) significantly improved immediately (5; IQR, 4–6; p < 0.001), 2 hours (5; IQR, 4–7; p = 0.003), and 6 hours
(6; IQR 4–6; p = 0.012) after paracentesis.
Conclusion: Paracentesis in critically ill patients is safe regarding circulatory function and is related to immediate
and sustained improvement of respiratory function.
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Hemodynamic monitoringBackground
Ascites is a major and frequent complication of liver
cirrhosis that is associated with high mortality [1-5]. The
first line management of uncomplicated ascites includes
dietary salt restriction and diuretics [6]. However, large or
refractory ascites often necessitates paracentesis [7,8].
Data on the safety and efficacy of large volume para-
centesis (LVP) regarding hemodynamic function are* Correspondence: wolfgang.huber@lrz.tum.de
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stated.contradictory. On the one hand, some studies suggest
that LVP might deteriorate cardiocirculatory function
or even induce circulatory failure [9,10]. On the other
hand, there are data showing that LVP with and without
post interventional intravenous albumin substitution
does not impair circulatory function and that it is more
effective and less associated with complications than
diuretic therapy [11-13]. Furthermore, ascites increases
intraabdominal pressure and abdominal pressure causes
impaired aeration of the lung in mechanically ventilated
patients [14,15]. A number of studies suggest improvedtd. This is an Open Access article distributed under the terms of the Creative
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the vast majority of studies on the subject of paracentesis
were not performed in critically ill patients with advanced
hemodynamic monitoring or mechanical ventilation.
As critically ill patients are often in a hemodynamical
unstable situation, LVP is likely to influence hemodynamics
in these patients more than in non-ICU (intensive care
unit) patients. Furthermore, estimation of volume status
based on physical examination in critically ill patients is
difficult [22]. This problem might be even more pro-
nounced in patients with ascites. Therefore, advanced
hemodynamic monitoring might help to accurately as-
sess the fluid status and hemodynamic changes particu-
larly in critically ill patients with ascites.
Therefore, the purpose of our study was to evaluate
potential effects of paracentesis on hemodynamic pa-
rameters and respiratory function in ICU patients moni-
tored using transpulmonary thermodilution (TPTD).
Methods
Study design, setting, patients, and data collection
We retrospectively analyzed a prospectively maintained
database of patients undergoing paracentesis and mon-
itored using TPTD (PiCCO®-device; Pulsion Medical
Systems SE, Feldkirchen, Germany). The study was ap-
proved by the local ethics committee (Ethikkommission
der Fakultät für Medizin der Technischen Universität
München). Eighty-one paracenteses in 50 patients per-
formed between January 2009 and July 2012 were eligible
for the study. To avoid repeated measurements, only
the first paracentesis of each patient was included in
the analysis. All patients were equipped with hemodynamic
monitoring irrespective of the study, and the decision
to perform paracentesis was made by the treating ICU
physician on clinical grounds independently from the
study. Considering a possible impact of paracentesis on
hemodynamic parameters as well as on the accuracy of
their assessment by pulse contour analysis, re-calibration
by TPTD after a major intervention is suggested by the
manufacturer and part of clinical routine [23]. The same
applies for the documentation of respiratory data before
and after paracentesis. Twenty-eight of 50 (56%) patients
were mechanically ventilated using pressure support venti-
lation or pressure control ventilation on the respirator
Evita XL (Dräger Medical GmbH, Lübeck, Germany) or
SERVO-i (Maquet, Rastatt, Germany). Data on ventilatory
parameters (tidal volume (Vt), maximal inspiratory pressure
(Pmax), positive end-expiratory pressure (PEEP), and
fraction of inspired oxygen (FiO2)) were recorded. Par-
tial arterial oxygen pressure (PaO2) and partial arterial
carbon dioxide pressure (PaCO2) were assessed using
a fully automatic blood gas analysis system (RAPID-
POINT400, Siemens Healthcare Diagnostics GmbH,
Eschborn, Germany). Laboratory, hemodynamic, respiratoryparameters, and patients’ characteristics were obtained
after analysis of the patients’ medical charts. Cumula-
tive points for lung injury score (LIS) without points
for chest roentgenogram and oxygenation ratio (PaO2/
FiO2) as well as inotropic score ((dopamine dose × 1) +
(dobutamine × 1) + (epinephrine dose × 100) + (norepin-
ephrine dose × 100) + (phenylephrine dose × 100)) and
vasopressor dependency index (inotropic score/MAP)
were calculated [24-27]. Hemodynamic parameters were
available for all 50 patients immediately before and
after paracentesis. Two hours after the end of paracen-
tesis, data of 33/50 (66%) patients and 6 hours after
paracentesis data of 34/50 (68%) were available. In
mechanically ventilated patients, data for dynamic respira-
tory system compliance (Vt/Pmax-PEEP) and LIS were
available immediately before paracentesis for all 28
patients, immediately after for 27/28 (96%). Data were
additionally available 2 and 6 hours after the end of para-
centesis in 21/28 (75%) and 18/28 (64%) patients, respect-
ively [24].
Paracentesis and TPTD
Total paracentesis (removal of ascites without any volume
restriction) was performed with a cannula (16–18 Gauge)
connected to a bag without suction in a supine position as
described before [28]. TPTD was performed as previously
described immediately before and after paracentesis
[29,30]. Albumin substitution was at the discretion of
the treating ICU physician [31].
Statistical analysis
All statistical analyses were performed using IBM SPSS
Statistics 20 (SPSS Inc, Chicago, Illinois, USA). Descrip-
tive statistics are presented as mean ± standard deviation
for normally distributed data and median, range, and
interquartile range (IQR) for non-normally distributed data.
Comparisons of hemodynamic and respiratory parameters
before and after paracentesis were performed by Wilcoxon
signed-rank tests. Bivariate relations were assessed by
Spearman’s correlation coefficient and univariate regression
analyses. Parameters with a corresponding p-value <0.1
were considered for multivariable linear regression ana-
lyses. Stepwise forward variable selection was performed
using likelihood ratio tests (inclusion criteria p < 0.05).
All statistical tests were 2-sided and performed in an
explorative manner on a 5% significance level.
Results
Patients’ characteristics are shown in Table 1.
Paracentesis
Fifty paracenteses in 50 patients were analyzed. The median
amount of ascites removed was 5.99 L (range, 0.49-17.06;
IQR 3.33 - 7.68 L). Within the 6 hours follow up after
Table 1 Patients’ characteristics
Demographic data (n = 50 patients)
Male sex, n/total (%) 27/50 (54%)
Age, years 58 ± 10
Body height, cm 171 ± 8
Body weight, kg 78 ± 18
Scores
SAPS II 42 ± 13
TISS 19 ± 7
APACHE II 20; 10–40; 17-27
Pre-existing medical conditions
Cirrhosis of the liver, n/total (%) 44/50 (88%)
Cirrhosis due to alcohol, n/total (%) 38/44 (86%)
Cirrhosis due to hepatitis, n/total (%) 4/44 (9%)
Cirrhosis due to unknown reason, n/total (%) 2/44 (5%)
Outcome
ICU mortality, n/total (%) 26/50 (52)
Hospital mortality, n/total (%) 33/50 (66)
Intervention related data
Amount of ascites removed, L 5.99; 0.49-17.06; 3.33-7.68
Duration of paracentesis, minutes 130; 45–300; 100-173
Speed of paracentesis, mL/minutes 44; 4–122; 28-61
Laboratory data
International normalized ratio (INR) 1.8; 1.1-4.1; 1.4-2.6
Partial thromboplastin time (PTT), seconds 57; 31–132; 45-75
Thrombocytes, ×109/L 58; 19–359; 37-82
Bilirubin, mg/dL 4.7; 0.6-52.0; 2.0-13.7
APACHE II, Acute Physiology and Chronic Health Evaluation II Score; n,
number; SAPS II, Simplified Acute Physiology Score II; TISS, Therapeutic
Intervention Scoring System.
Data is presented as mean ± standard deviation, or median, range, and
interquartile range or n/total (%).
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500 mL; IQR, 0–200 mL) of 20% human albumin and a me-
dian volume of 350 mL (range, 0–830 mL; IQR, 203–565
mL) crystalloid infusions were administered.
Serum and ascites protein levels
The serum protein values within 72 hours before (median,
5.2 g/dL; range, 3.8-7.1 g/dL; IQR, 4.8-5.9 g/dL) and 72
hours after (median, 5.4 g/dL; range, 3.7-6.6 g/dL; IQR,
4.5-5.7 g/dL) paracentesis were available in 34/50 (68%)
patients. The difference was statistically not significant
(p = 0.068). Data for calculating the serum ascites protein
gradient (SAPG) were available for 39/50 (78%) patients.
Median SAPG was 4.1 (range, 2.5-6.5; IQR, 3.3-4.8).
Hemodynamics
Compared to baseline values, there were no statistically
significant changes in hemodynamic parameters immedi-ately, 2 hours and 6 hours after paracentesis except decrease
of mean arterial pressure (MAP, -7 mm Hg; p = 0.041) and
systemic vascular resistance index (SVRI, -116 dyne·sec/
cm5/m2; p = 0.016) when measured 2 hours after paracen-
tesis. Hemodynamic parameters before paracentesis as
well as immediately, 2 hours, and 6 hours after the end of
paracentesis are shown in Table 2.
Subgroup analysis including only mechanically ventilated
patients did not reveal statistically significant or clinically
relevant paracentesis-induced changes in hemodynamic
parameters.
Vasopressor dependency index for all patients (median
before paracentesis 0.0; IQR 0.0-374.1) did not change
statistically significantly when measured immediately (me-
dian, 0.0; IQR, 0.0-343.4; p = 0.876), 2 hours (median, 0.0;
IQR, 0.0-493.8; p = 0.650), and 6 hours (median, 0.0; IQR,
0.0-288.2; p = 0.711) after paracentesis. Subgroup analysis
including only mechanically ventilated patients revealed
similar results with a median vasopressor dependency
index before paracentesis of 243.9 (IQR 0.0-735.3) and
no statistically significant changes immediately (median,
253.2; IQR, 0.0-735.3; p = 0.679), 2 hours (median, 241.0;
IQR, 0.0-762.3; p = 0.701), and 6 hours (median, 142.9;
IQR, 0.0-709.7; p = 0.776) after paracentesis.
Subgroup analysis of patients undergoing paracentesis of
more than 5 liters (n = 32) and more than 10 liters (n = 6)
did not show any additional statistically significant changes
in circulatory or TPTD derived parameters at any time-
point measured.
Respiratory function
In mechanically ventilated patients, a median baseline LIS
of 6 points (IQR 4–7 points) and a median PaO2/FiO2
of 220 mmHg (IQR 161–329 mmHg) indicated severe
respiratory dysfunction. In these patients, respiratory
function markedly improved following paracentesis. Com-
pared with the baseline values before paracentesis, LIS
significantly improved immediately (−1 point; p < 0.001), 2
hours (−1 point; p = 0.003) and 6 hours (±0 points;
p = 0.012) after paracentesis (Table 3). Similarly, PaO2/
FiO2 significantly improved immediately (+54 mmHg;
p < 0.001) and 2 hours (+24 mmHg; p = 0.001) after
paracentesis. Furthermore, compliance significantly in-
creased by 5.5 mL/cm H2O (p = 0.032) and 4.9 mL/cm
H2O (p = 0.030) immediately and 2 hours after the end
of paracentesis, respectively. Likewise to the subgroup
of mechanically ventilated patients, PaO2/FiO2 statisti-
cally significantly increased also for all patients. Table 3
shows baseline respiratory parameters as well as values
obtained immediately, 2 hours, and 6 hours after the
end of paracentesis.
In univariate analysis including only mechanically venti-
lated patients, the amount of ascites removed (p = 0.013)
and the parameters LIS before paracentesis (p = 0.004)
Table 2 Hemodynamic data before and after paracentesis
Before paracentesis Immediately after
paracentesis
p-value 2 hours after
paracentesis
p-value 6 hours after
paracentesis
p-value
Heart rate, beats per minute 88 (79–101) 88 (80–100) 0.340 91 (81–99) 0.152 90 (85–99) 0.530
MAP, mmHg 84 (76–93) 79 (73–88) 0.060 77 (71–90) 0.041* 80 (71–89) 0.213
CI, L/min/m2 4.6 (3.7-5.4) 4.6 (3.6-5.6) 0.211 4.7 (3.7-5.7) 0.304 4.9 (3.8-5.7) 0.402
GEDVI, mL/m2 817 (697–909) 820 (713–941) 0.787 784 (711–900) 0.943 792 (685–861) 0.669
SVRI, dyne·sec/cm5/m2 1163 (883–1606) 1120 (869–1443) 0.118 1047 (882–1370) 0.016* 1116 (877–1406) 0.270
EVLWI, mL/m2 10 (7–12) 10 (8–12) 0.442 10 (8–13) 0.129 10 (8–12) 0.338
Norepinephrine dose, μg/h 0.0 (0.0-300.0) 0.0 (0.0-325.0) 0.812 0.0 (0.0-375.0) 0.979 0.0 (0.0-238.0) 0.905
MAP, mean arterial pressure; CI, cardiac index; GEDVI, global end-diastolic volume index; SVRI, systemic vascular resistance index; EVLWI, extravascular lung
water index.
Data are presented as: median (interquartile range). Tests are performed against the baseline values. p-values <0.05 are indicated with*.
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significantly associated with paracentesis-induced changes
in LIS when determined immediately after paracentesis.
No statistically significant association was seen for sim-
plified acute physiology score II (SAPS II) (p = 0.846),
therapeutic intervention scoring system (TISS) (p = 0.950),
dynamic respiratory system compliance before paracen-
tesis (p = 0.350), and model for end-stage liver disease
(MELD) score (p = 0.704). Subsequent multivariate linear
regression analysis including the factors univariately asso-
ciated confirmed LIS before paracentesis (p = 0.003) and
amount of ascites removed (p = 0.009) as independent
factors regarding improvement of LIS immediately after
paracentesis compared with baseline values (Table 4).
Renal function
Despite a median negative 24-hour fluid balance on the
day of intervention of −4.2 L (IQR, -6.0 L to −1.8 L),
the median 24-hour urine output on the day after para-
centesis (median, 800 mL; IQR, 250–1850 mL) was signifi-
cantly higher (+200 mL; p = 0.015) when compared with
the day before the intervention (median, 600 mL; IQR,
200–1300 mL).Table 3 Respiratory parameters before and after paracentesis
Before paracentesis Immediat
paracente
PaO2, mmHg 82.5 (72.9-98.6) 90.1 (82.5-
PaCO2, mmHg 39.0 (31.0-51.3) 40.3 (31.6-
PaO2/FiO2, mmHg 220 (161–329) 278 (195–3
FiO2, % (mechanically ventilated patients) 48 (40–64) 45 (35–60)
PaO2/FiO2, mmHg
(mechanically ventilated patients)
188 (136–233) 242 (184–2
Vt/(Pmax-PEEP), mL/cmH2O
(mechanically ventilated patients)
30.1 (21.2-57.6) 35.6 (24.8-
Lung injury score (without x-ray)
(mechanically ventilated patients)
6 (4–7) 5 (4–6)
PaO2, partial arterial oxygen pressure; PaCO2, partial arterial carbon dioxide pressure
positive end-expiratory pressure; Vt, tidal volume.
Data is presented as median (interquartile range). Tests are performed against the bComplications
Despite a marked general risk profile of the patients
population in our study (mean SAPS II on the day of
intervention 42 ± 13 points) and impaired blood coagu-
lation tests (median INR 1.8 (IQR 1.4-2.6), median partial
thromboplastin time 57 seconds (IQR, 45–75 seconds),
median platelet count 58 × 109/L (IQR, 37–82 × 109/L);
Table 1), no major bleeding or other intervention-related
complications occurred.Discussion
In this trial we analyzed the effects of paracentesis on
hemodynamic parameters and respiratory function in
critically ill patients.
According to the results of our study, no relevant im-
pairment of circulatory function was observed whereas
renal function in terms of urine output improved fol-
lowing removal of ascites. Furthermore, paracentesis is
related to immediate and sustained improvement of
respiratory function. The median oxygenation ratio of
all patients increased, whereas PaCO2 remained stable
after paracentesis.ely after
sis
p-value 2 hours after
paracentesis
p-value 6 hours after
paracentesis
p-value
110.0) 0.001* 91.6 (76.1-103.2) 0.044* 87.9 (74.5-94.8) 0.645
45.3) 0.156 40.4 (31.7-48.6) 0.665 40.7 (32.0-47.8) 0.486
90) 0.001* 229 (167–354) 0.004* 226 (162–327) 0.050
0.016* 45 (38–53) 0.004* 45 (40–55) 0.007*
84) <0.001* 212 (163–266) 0.001* 201 (152–274) 0.078
60.0) 0.032* 35.0 (23.8-61.1) 0.030* 35.6 (28.6-55.5) 0.062
<0.001* 5 (4–7) 0.003* 6 (4–6) 0.012*
; FiO2, fraction of inspired oxygen; Pmax, maximal inspiratory pressure; PEEP,
aseline values. p-values <0.05 are indicated with*.
Table 4 Factors associated with changes of LIS immediately before and after paracentesis in mechanically
ventilated patients
Univariate regression analyses Multivariate regression analysis
Intercept Coefficient r p-value Intercept Coefficient p-value
Amount of ascites removed 0.026 −0.170 0.470 0.013* 1.517 −0.154 0.009*
LIS before paracentesis 0.638 −0.298 0.537 0.004* −0.277 0.003*
PaO2/FiO2 −2.549 0.008 0.476 0.012*
SAPS II −1.254 0.004 0.039 0.846
TISS −1.123 0.002 0.013 0.950
Lung compliance −1.258 0.004 0.187 0.350
MELD score −0.804 −0.010 0.077 0.704
LIS, lung injury score (cumulative points without x-ray); PaO2, partial arterial oxygen pressure; FiO2, fraction of inspired oxygen; SAPS II, simplified acute physiology score
II; TISS, therapeutic intervention scoring system; lung compliance calculated as Vt/Pmax-PEEP, mL/cmH2O; MELD score, model for end-stage liver disease score.
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culatory dysfunction [32]. Portal hypertension leads to
vasodilatation of splanchnic vessels, leading to decreased
peripheral resistance, decreased effective central blood vol-
ume with consequent arterial hypotension and hyperdy-
namic circulation. These changes finally result in activation
of vasoconstrictor systems, the renin-angiotensin-
aldosteron system (RAAS) and the sympathetic nervous
system, as well as increased levels of antidiuretic hormone,
water retention and renal vasoconstriction, possibly ending
in renal failure [33-35]. Infusion of albumin is recom-
mended by the American Association for the Study of
Liver Diseases (AASLD) for large volume paracentesis
(> 5 Liter), because intravenously administered albumin
increases the effective arterial blood volume and improves
serum sodium concentrations in patients with cirrhosis
and severe hyponatremia [36-40]. However, albumin does
not interfere with the main mechanisms of ascites forma-
tion and therefore only prevents complications of paracen-
tesis rather than prevents the recurrence of ascites [10].
Regarding hemodynamic parameters, paracentesis did
neither result in an immediate nor in a delayed cardio-
circulatory impairment. No statistically significant changes
in arterial blood pressure, heart rate, or TPTD-derived
parameters such as cardiac index (CI), global end diastolic
volume index (GEDVI), and extra vascular lung water
index (EVLWI) were observed after paracentesis. This
is partly in contrast to some previous studies demonstrating
a paracentesis-related deterioration of cardiac function and
might be explained by the fact that volume resuscitation
was guided using advanced hemodynamic monitoring
in the patients included in our study during their ICU
stay. This might have resulted in an optimized baseline
(pre-paracentesis) hemodynamic and intravascular volume
status in our patients indicated by normal baseline values
for MAP, CI, and GEDVI assessed using advanced hemo-
dynamic monitoring [9,41-43]. Two hours after the inter-
vention, MAP and SVRI were statistically significantly
lower compared with the values before the intervention.However, 6 hours after the end of paracentesis, there was
no statistically significant difference in MAP and SVRI
compared with baseline values anymore. These paracen-
tesis-related hemodynamic changes (decreased SVRI,
unchanged GEDVI) two hours after the end of paracentesis
are most likely due to a reduction of cardiac afterload
as a consequence of a paracentesis-induced lower intraab-
dominal pressure [28]. In addition, the reduction of SVRI
after paracentesis might be explained by the substitution
of albumin following paracentesis. A significant reduction
of SVRI after plasma-expansion with hyperoncotic al-
bumin in cirrhotic patients with renal failure has been
described before [34,43]. However, Cabrera et al. observed
no decrease of SVRI when removing ascites but maintain-
ing the intraabdominal pressure at its original level in an
experimental setting using a pneumatic girdle. Only after
decrease of intraabdominal pressure, SVRI also decreased
[44]. Since application rates of vasoactive drugs and the
vasopressor dependency index were not significantly
different before and after paracentesis, the decrease in
SVRI in our study cannot be explained by a lower applica-
tion rate of vasopressors following paracentesis. Based
on the considerations mentioned before, the decrease
in SVRI observed following removal of ascites is most
likely caused by a paracentesis-related reduction of intraab-
dominal pressure [28,45]. Unfortunately, documentation of
intraabdominal pressure before and after paracentesis is
not routinely performed in our ICU and was therefore not
available for data analysis.
Given the fact, that all hemodynamic parameters were
stable 6 hours after the end of paracentesis and that
vasopressor dependency index did not change statistically
significantly, LVP seems to be a safe procedure regarding
circulatory function.
Regarding the positive impact of paracentesis on respi-
ratory function, an improvement of oxygenation (while
PaCO2 remained unchanged) was also observed in a previ-
ous study [18]. These positive effects regarding respiratory
function are most likely due to improved respiratory
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reduction of intraabdominal pressure [18,21,46]. The
fact that paracentesis caused a significant improvement
of dynamic respiratory system compliance in mechanically
ventilated patients is also indicative for a decreased intraab-
dominal pressure following paracentesis. These findings
are in accordance with the results from a recent study
by Levesque and colleagues in 31 mechanically ventilated
cirrhotic patients demonstrating a significant decrease
in intraabdominal pressure, improvement of oxygenation,
and an increase in end-expiratory lung volume after LVP
[21]. The improvement of dynamic respiratory system
compliance, LIS, and PaO2/FiO2 in mechanically venti-
lated patients demonstrates the possibility to reduce
ventilator associated lung injury by removal of ascites
in these patients.
The median urine output on the day after paracentesis
was significantly higher compared with the day before
the intervention. This indicates, as described before by
our group and others, that paracentesis might help to
improve renal function [43,47]. The increase of urine
output on the day after paracentesis despite a negative
fluid balance on the day of paracentesis indicates that
the reduction of intraabdominal pressure – besides possible
humoral effects – is causative for the improvement of
renal function [48].Limitations of the study
There are several limitations of our study that need to be
mentioned. In general, since we studied a limited number
of paracenteses in a monocentric study, the results of our
study need to be interpreted with caution. Especially the
number of patients on mechanical ventilation is relatively
low in our study. In addition, documentation of intraab-
dominal pressure before and after paracentesis is not
routinely performed and therefore not available for data
analysis. Finally, albumin substitution after paracentesis
was at the discretion of the treating ICU physician and was
not performed strictly adhering to international guidelines.Conclusion
Our data indicate that paracentesis in critically ill patients
is safe regarding hemodynamic function, renal function
and intervention-related complications. Furthermore, para-
centesis in critically ill and mechanically ventilated patients
results in immediate and sustained improvement of
respiratory function. Paracentesis might therefore help
to limit ventilator associated lung injury.
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